Germany’s Merck Set to Buy SpringWorks in $3.9 Billion Deal
In This Article:
The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.